Binding of alanine‐substituted peptides to the MHC class I protein, Kd
- 8 February 1993
- journal article
- Published by Wiley in FEBS Letters
- Vol. 317 (1-2) , 49-52
- https://doi.org/10.1016/0014-5793(93)81489-m
Abstract
Peptides eluted from the native MHC class I molecule, K d , are generally nonamers that display a strong preference for Tyr in position 2. We investigated the molecular basis for this ‘consensus motif’ by synthesizing a virally derived peptide, NP 147–155, that is known to be presented by K d on living cells, and peptide variants of NP 147–155 in which the amino acids in the different positions were sequentially replaced by Ala. All of the peptides bound to purified K d molecules in vitro with high affinity, except for the peptide in which Tyr 2 was replaced by Ala, for which the affinity for K d decreased at least 100-fold. These results confirm the interpretation of the in vivo studies; namely, that Tyr 2 is a critical anchor residue for binding to K d .Keywords
This publication has 22 references indexed in Scilit:
- Crystal Structures of Two Viral Peptides in Complex with Murine MHC Class I H-2K bScience, 1992
- The identification of tyrosine as a common key residue in unrelated H-2Kd restricted antigenic peptidesInternational Immunology, 1991
- The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformationNature, 1991
- H-2Kd-restricted antigenic peptides share a simple binding motif.The Journal of Experimental Medicine, 1991
- Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC moleculesNature, 1991
- Antigen Recognition by Class I-Restricted T LymphocytesAnnual Review of Immunology, 1989
- Enhanced recognition of a modified peptide antigen by cytotoxic T cells specific for influenza nucleoproteinCell, 1988
- Solid Phase SynthesisScience, 1986
- The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptidesCell, 1986
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973